STRO
Sutro BiopharmaNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$636.04M
P/E Ratio
—
EPS
$-24.30
Beta
1.64
52W High
$39.10
52W Low
$6.74
50-Day MA
$26.37
200-Day MA
$14.37
Dividend Yield
—
Profit Margin
-186.50%
Forward P/E
8.96
PEG Ratio
—
About Sutro Biopharma
Sutro Biopharma, Inc. is a clinical stage drug discovery, development and manufacturing company. The company is headquartered in South San Francisco, California.
Fundamentals
| Revenue (TTM) | $102.48M |
| Gross Profit (TTM) | $-63.93M |
| EBITDA | $-97.63M |
| Operating Margin | -289.00% |
| Return on Equity | -1810.00% |
| Return on Assets | -23.40% |
| Revenue/Share (TTM) | $12.06 |
| Book Value | $-15.43 |
| Price-to-Book | 1.65 |
| Price-to-Sales (TTM) | 6.21 |
| EV/Revenue | 4.518 |
| EV/EBITDA | 41.71 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -21.40% |
| Shares Outstanding | $16.57M |
| Float | $13.31M |
| % Insiders | 2.30% |
| % Institutions | 44.14% |
Historical Volatility
HV 10-Day
57.09%
HV 20-Day
67.68%
HV 30-Day
66.56%
HV 60-Day
76.42%
HV Rank
2.8%
Volatility is currently contracting
Analyst Ratings
Consensus ($35.73 target)
2
Strong Buy8
Buy1
Hold1
Strong SellMore HEALTHCARE Stocks
Data last updated: 5/5/2026